SCHEMBL5634867

SCHEMBL5634867

CN1C2CCC1CC(Sc1cccc(Cl)c1)C2

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.43
OPRK1 P41145 1/20 0.43
KCNH2 Q12809 1/20 0.43
DDB1 Q16531 1/20 0.42
CRBN Q96SW2 1/20 0.42
CHRM1 P11229 2/20 0.39
SLC6A2 P23975 2/20 0.39
SLC6A4 P31645 2/20 0.39
DRD3 P35462 2/20 0.39
SLC6A3 Q01959 1/20 0.39
MEN1 O00255 2/20 0.39
MAPT P10636 2/20 0.39
KMT2A Q03164 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
NFKB1 P19838 1/20 0.39
THPO P40225 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14573367 0.83 KMT2A (0.45) OPRM1OPRK1KCNH2DDB1CRBN
SCHEMBL5635606 0.82 OPRK1 (0.43) OPRM1OPRK1KCNH2CHRM1SLC6A2
SCHEMBL5635602 0.82 OPRK1 (0.43) OPRM1OPRK1KCNH2CHRM1SLC6A2
SCHEMBL7940536 0.81 SLC6A3 (0.50) CHRM1SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL5634899 0.80 SLC6A2 (0.50) OPRM1OPRK1KCNH2CHRM1SLC6A2
SCHEMBL5634904 0.80 SLC6A2 (0.50) OPRM1OPRK1KCNH2CHRM1SLC6A2
SCHEMBL1177473 0.80 SLC6A4 (0.50) CHRM1SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL1177474 0.80 SLC6A4 (0.50) CHRM1SLC6A2SLC6A4DRD3SLC6A3
SCHEMBL5636477 0.79 DDB1 (0.46) OPRM1OPRK1KCNH2DDB1CRBN
SCHEMBL14573359 0.79 DDB1 (0.46) OPRM1OPRK1KCNH2DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070054912-A1 Modulators of acetylcholine receptors ASTLES PETER C 2007-03-08 US disclosed
US-7148236-B2 Modulators of acetylcholine receptors MERCK & CO., INC. (US) 2006-12-12 US disclosed
US-20050182088-A1 Modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-08-18 US disclosed
EP-1472248-A1 MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2004-11-03 EP disclosed
WO-2003062235-A1 MODULATORS OF ACETYLCHOLINE RECEPTORS ELI LILLY AND COMPANY (US) 2003-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050182088-A1 Modulators of acetylcholine receptors CHRM3, CHRNG, CHRM5 OPRM1 103/4885OPRK1 70/4885KCNH2 518/4885
US-20070054912-A1 Modulators of acetylcholine receptors CHRM3, CHRNG, CHRM5 OPRM1 43/4885OPRK1 51/4885KCNH2 655/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.